Screener
Madrigal Pharmaceuticals, Inc. MDGL EPS (Basic)
EPS (Basic) at other companies
Other financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.
The source filing: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 9:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050845
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Loss from operations | (56,308) | (47,202) | (149,031) | (126,513) |
| Interest income | 7,104 | 8,227 | 15,347 | 17,597 |
| Interest expense | (7,940) | (3,264) | (15,759) | (6,561) |
| Other expense, net | (795) | (42) | (2,887) | (42) |
| Net loss | $(57,939) | $(42,281) | $(152,330) | $(115,519) |
| Net loss per common, Series A preferred and Series B preferred share: | ||||
| Basic and diluted net loss per common, Series A preferred, and Series B preferred share | $(1.99) | $(1.50) | $(5.24) | $(4.10) |
| Basic and diluted weighted average number of shares outstanding (Note 13) | 29,145,271 | 28,232,604 | 29,089,148 | 28,159,333 |
Item 1. Financial Statements (Unaudited):
FAQ
- What is Madrigal Pharmaceuticals, Inc.'s EPS (basic)?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported EPS (basic) of -$1.99 in Q2 2026.
- How has Madrigal Pharmaceuticals, Inc.'s EPS (basic) changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s EPS (basic) decreased by 4.7% year-over-year, from -$1.90 to -$1.99.
- What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s EPS (basic)?
- Over 4 years (2021 to 2025), Madrigal Pharmaceuticals, Inc.'s EPS (basic) has grown at a -3.2% compound annual growth rate (CAGR), from -$14.61 to -$12.83.
- What does EPS (basic) mean?
- Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.
Ask your AI about Madrigal Pharmaceuticals, Inc.'s eps (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude